Cyclacel Pharmaceuticals (CYCCP) Competitors

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Notice: This company has been marked as potentially delisted and may not be actively trading.

Stock Analysis Competitors Dividend Headlines Social Media

CYCCP vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW

Should you be buying Cyclacel Pharmaceuticals stock or one of its competitors? The main competitors of Cyclacel Pharmaceuticals include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Cassava Sciences (SAVAW). These companies are all part of the "biotechnology" industry.

Cyclacel Pharmaceuticals vs.

Cyclacel Pharmaceuticals (NASDAQ:CYCCP) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends, risk and community ranking.

: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Cyclacel Pharmaceuticals N/A N/A N/A N/A N/A
180 Life Sciences N/A N/A N/A N/A N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cyclacel Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
180 Life Sciences
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: Cyclacel Pharmaceuticals received 97 more outperform votes than 180 Life Sciences when rated by MarketBeat users.
Company Underperform Outperform
Cyclacel Pharmaceuticals Outperform Votes
97
67.36%
Underperform Votes
47
32.64%
180 Life Sciences N/A N/A
: In the previous week, Cyclacel Pharmaceuticals' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.
Company Overall Sentiment
Cyclacel Pharmaceuticals Neutral
180 Life Sciences Neutral
: Company Net Margins Return on Equity Return on Assets
Cyclacel Pharmaceuticals N/A N/A N/A
180 Life Sciences N/A N/A N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cyclacel Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
180 Life Sciences	N/A	N/A	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cyclacel Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
180 Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Underperform	Outperform
Cyclacel Pharmaceuticals	Outperform Votes 97 67.36%	Underperform Votes 47 32.64%
180 Life Sciences	N/A	N/A

Company	Overall Sentiment
Cyclacel Pharmaceuticals	Neutral
180 Life Sciences	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Cyclacel Pharmaceuticals	N/A	N/A	N/A
180 Life Sciences	N/A	N/A	N/A

Summary

Cyclacel Pharmaceuticals beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

Get Cyclacel Pharmaceuticals News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CYCCP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CYCCP vs. The Competition

Export to Excel

Metric	Cyclacel Pharmaceuticals	Biotechnology Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$310.69M	$4.74B	$7.44B
Dividend Yield	0.12%	3.47%	2.97%	4.00%
P/E Ratio	N/A	230.94	270.35	19.17
Price / Sales	N/A	11,794.50	2,512.90	85.89
Price / Cash	N/A	11.29	46.85	35.12
Price / Book	N/A	5.76	4.58	4.19
Net Income	N/A	-$22.67M	$104.24M	$214.15M

Cyclacel Pharmaceuticals Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	Employee Count	Indicator(s)
ATNFW 180 Life Sciences	0 of 5 stars	$0.01 flat	N/A	-47.9%	$0.00	N/A	4	Gap Up
SXTPW 60 Degrees Pharmaceuticals	0 of 5 stars	$0.11 flat	N/A	N/A	$0.00	$90,718.00	2	Positive News
DRTSW Alpha Tau Medical	0 of 5 stars	$0.26 +4.0%	N/A	+6.8%	$0.00	N/A	121	News Coverage Positive News Gap Down
APLMW Apollomics	0 of 5 stars	$0.03 flat	N/A	-77.8%	$0.00	N/A	59	Gap Up
ARTLW Artelo Biosciences	0 of 5 stars	$0.02 flat	N/A	N/A	$0.00	N/A	5	Positive News
BCDAW BioCardia	0 of 5 stars	$0.03 +50.5%	N/A	-98.0%	$0.00	$477,000.00	30	Positive News Gap Down
BCTXW BriaCell Therapeutics	0 of 5 stars	$1.08 -12.9%	N/A	-67.0%	$0.00	N/A	16	Positive News Gap Up High Trading Volume
CDIOW Cardio Diagnostics	0 of 5 stars	$0.08 +14.3%	N/A	-74.8%	$0.00	$17,065.00	7	Positive News Gap Down
CTCXW Carmell	0 of 5 stars	$0.15 flat	N/A	N/A	$0.00	$3.73M	9	Positive News
SAVAW Cassava Sciences	0 of 5 stars	$6.17 +38.6%	N/A	N/A	$0.00	N/A	29	Positive News Gap Down

Related Companies and Tools

Related Companies:

Top 10 Stock Comparisons

This page (NASDAQ:CYCCP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cyclacel Pharmaceuticals (CYCCP) Competitors

CYCCP vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW

Cyclacel Pharmaceuticals vs.

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CYCCP vs. The Competition

Cyclacel Pharmaceuticals Competitors List

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info